QBE
LIVE

Serial Number

79426343

Owner

Glatt GmbH

Attorney

Bryan P. Clark

Filing Date

May 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

QBE Trademark

Serial Number: 79426343

QBE is a trademark filed by Glatt GmbH on May 15, 2025. The trademark is classified under Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 11 (Environmental Control). The application is currently pending registration.

Owner Contact Info

Glatt GmbH (23 trademarks)

Binzen 79589 , DE

Entity Type: 99

Trademark Details

Filing Date

May 15, 2025

Registration Date

Not Registered

Goods & Services

Cell culture apparatus for medical use, namely bioreactors for medical use; bioreactors for cell culturing for medical purposes; cell culture apparatus for medical use namely, clinical cell culture incubators, tissue culture systems comprised of incubators for medical purposes, sample preparation device for medical diagnostic uses in the nature of blood and cell separators, bioreactors, aseptic isolators being sample preparation devices for medical diagnostic uses, sample preparation device for medical diagnostic uses in the nature of automated cell and media exchange systems, clinical-grade microscopes with image analysis for surgical operations, flow cytometers for medical diagnostic uses, automated cell counters with viability in the nature of flow cytometers and flow-based analyzers providing cell counting for medical, clinical, medical diagnostic, and therapeutic uses, sample preparation device for medical diagnostic uses in the nature of media and reagent preparation systems, and cell banking systems, for medical use comprised of sample preparation device for medical diagnostic uses; cell culture apparatus for medical use, namely, fermenter apparatus for medical purposes; cell culture systems for medical purposes comprised of clinical cell culture incubators, tissue culture systems comprised of incubators for medical purposes, sample preparation device for medical diagnostic uses in the nature of blood and cell separators, bioreactors, aseptic isolators being sample preparation devices for medical diagnostic uses, sample preparation device for medical diagnostic uses in the nature of automated cell and media exchange systems, clinical-grade microscopes with image analysis for surgical operations, flow cytometers for medical diagnostic uses, automated cell counters with viability in the nature of flow cytometers and flow-based analyzers providing cell counting for medical, clinical, medical diagnostic, and therapeutic uses, sample preparation device for medical diagnostic uses in the nature of media and reagent preparation systems, and cell banking systems comprised of sample preparation device for medical diagnostic uses; cell culture apparatus for medical use, namely, racks for cell culture systems, in particular in the form of bioreactors and fermenter apparatus, for medical purposes; cell culture apparatus for medical use, namely, racks for bioreactors for medical purposes; cell culture apparatus for medical use, namely, racks for fermenter apparatus for medical purposes; structural parts for the aforesaid goods.

Bioreactors for cell culturing for scientific research; cell culture apparatus for laboratory use, namely, disposable reaction vessels of plastic for cell cultures; cell culture apparatus for scientific use, namely bioreactors, cell culture dishes, cell culture plates, cell culture flasks, tissue culture flasks, sterile filters, and cell strainers; cell culture apparatus for laboratory use, namely bioreactors, cell culture dishes, cell culture plates, cell culture flasks, tissue culture flasks, sterile filters, and cell strainers; cell culture systems for scientific use comprised of cell culture apparatus for laboratory use, namely bioreactors, cell culture dishes, cell culture plates, cell culture flasks, tissue culture flasks, sterile filters, and cell strainers; racks being structural parts for cell culture systems, in particular in the form of bioreactors and fermenter apparatus, for scientific use; racks being structural parts for bioreactors for scientific use; racks being structural parts for fermenter apparatus for scientific use; structural parts for all of the aforesaid goods.

Fermentation apparatus for industrial purposes; Fermentation apparatus for the manufacture of biopharmaceuticals; racks being structural parts for fermentation apparatus for industrial purposes; structural parts for the aforesaid goods.

Bioreactors for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; bioreactors for cell culturing for industry for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; cell culture apparatus being machines for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; cell culture systems for industrial use comprised of machines for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; racks being machine parts for cell culture systems in the form of bioreactors for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; racks being machine parts for bioreactors for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; installations in the nature of machines for the production of pharmaceuticals; bioreactors for use in manufacturing biopharmaceuticals; structural parts for the aforesaid goods.

Filing History

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 9, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 9, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 9, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 9, 2026 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 2, 2026 CNRT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 21, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 21, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 21, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2026 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2026 TROA
REFUSAL PROCESSED BY IB
Dec 5, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 19, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 19, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 29, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2025 REPR